The global crisis of multidrug resistance: how to face healthcare associated infections without effective antibiotics?
Abstract
No Abstract
Walsh TR, Toleman MA. The emergence of pan-resis- tant Gram-negative pathogens merits a rapid global po- litical response. J Antimicrob Chemother 2012; 67: 1-3.
Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB et al. Bad bugs, no drugs: no ES- KAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 2009; 48: 1-12.
White AR; BSAC Working Party on The Urgent Need: Regenerating Antibacterial Drug Discovery and De- velopment. Effective antibacterials: at what cost? The economics of antibacterial resistance and its control. J Antimicrob Chemother 2011; 66: 1948-1953.
van der Bij AK, Pitout JD. The role of international travel in the worldwide spread of multiresistant Enter- obacteriaceae. J Antimicrob Chemother 2012; 67:2090-2100.
Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL. Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. ClinMicrobiol Rev 2012;25: 682-707.
Clements A, Halton K, Graves N, Pettitt A, Morton A, Looke D, et al.Over crowding and understaffing in mod- ern health-care systems: key determinants inmeticillin- resistant Staphylococcus aureus transmission. Lancet Infect Dis 2008; 8: 427-434.
Kaier K, Mutters NT, Frank U. Bed occupancy rates and hospital-acquired infections--should beds be kept empty? Clin Microbiol Infect 2012; 18: 941-945.
Tamma PD, Savard P, Pál T, Sonnevend Á, Perl TM, Milstone AM. An outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neo- natal intensive care unit. Infect Control Hosp Epidemiol 2012; 33: 631-634.
| Files | ||
| Issue | Vol 5 No 2 (2013) | |
| Section | Articles | |
| Keywords | ||
| No Keywords | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
